Civic Intelligence

Peptide Therapeutics Foundation

990EZ • Fiscal year 2018 • EIN 26-3728931

Jan 01, 2018 to Dec 31, 2018 • Filed on Mar 12, 2019

4245 Sorrento Valley BlvdSan Diego, CA 92121

(858) 657-1511

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

59th percentile

0.00x

Higher debt load relative to assets than 59% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Liabilities / Revenue

65th percentile

0.01x

Higher debt load relative to revenue than 65% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Net Margin

72nd percentile

17%

Higher net margin than 72% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2018 filings • 501(c)3 • <$500k nonprofits • Source year 2018

Asset Growth

30th percentile

-9.4%

Faster asset growth than 30% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Annualized from 2017 to 2018

Revenue Growth

20th percentile

-26%

Faster revenue growth than 20% of similar nonprofits.

2018 filings • 501(c)3 • <$500k nonprofits • Annualized from 2017 to 2018

Assets

Down

$433,418

Down $45,146 (-9.4%) from 2017

Net Assets

Up

$432,122

Up $21,358 (+5.2%) from 2017

Liabilities

Down

$1,296

Down $66,504 (-98%) from 2017

Revenue

Down

$127,978

Down $44,596 (-26%) from 2017

Expenses

Down

$106,620

Down $919 (-0.9%) from 2017

Net Income

Down

$21,358

Down $43,677 (-67%) from 2017

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$600K$400K$200K$0Assets 2013: $321,273Liabilities 2013: $47,078Net Assets 2013: $274,1952013Assets 2014: $348,771Liabilities 2014: $49,919Net Assets 2014: $298,8522014Assets 2015: $389,214Liabilities 2015: $58,059Net Assets 2015: $331,1552015Assets 2016: $404,349Liabilities 2016: $58,620Net Assets 2016: $345,7292016Assets 2017: $478,564Liabilities 2017: $67,800Net Assets 2017: $410,7642017Assets 2018: $433,418Liabilities 2018: $1,296Net Assets 2018: $432,1222018Assets 2019: $442,929Liabilities 2019: $431Net Assets 2019: $442,4982019Assets 2020: $442,709Liabilities 2020: $2,807Net Assets 2020: $439,9022020Assets 2021: $373,700Liabilities 2021: $197Net Assets 2021: $373,5032021Assets 2022: $281,743Liabilities 2022: $500Net Assets 2022: $281,2432022Assets 2023: $286,944Net Assets 2023: $286,9442023Assets 2024: $335,263Net Assets 2024: $335,2632024

Highlighted filing

2018

Assets$433,418
Liabilities$1,296
Net Assets$432,122

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$200K$100K$0-$100KRevenue 2013: $122,329Expenses 2013: $101,707Net Income 2013: $20,6222013Revenue 2014: $137,675Expenses 2014: $113,018Net Income 2014: $24,6572014Revenue 2015: $142,758Expenses 2015: $110,455Net Income 2015: $32,3032015Revenue 2016: $136,200Expenses 2016: $121,626Net Income 2016: $14,5742016Revenue 2017: $172,574Expenses 2017: $107,539Net Income 2017: $65,0352017Revenue 2018: $127,978Expenses 2018: $106,620Net Income 2018: $21,3582018Revenue 2019: $121,265Expenses 2019: $110,889Net Income 2019: $10,3762019Revenue 2020: $43,680Expenses 2020: $46,276Net Income 2020: -$2,5962020Revenue 2021: $66,103Expenses 2021: $115,909Net Income 2021: -$49,8062021Revenue 2022: $110,022Expenses 2022: $129,463Net Income 2022: -$19,4412022Revenue 2023: $134,883Expenses 2023: $157,903Net Income 2023: -$23,0202023Revenue 2024: $174,477Expenses 2024: $144,680Net Income 2024: $29,7972024

Highlighted filing

2018

Revenue$127,978
Expenses$106,620
Net Income$21,358
Jump To
Filing Snapshot
Filing Period
Jan 1, 2018 to Dec 31, 2018
Signed
Mar 12, 2019
Return Version
2018v3.1
Gross Receipts
$127,978
Mission and Program Overview

Mission

The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.

Program Services

DescriptionGrantsExpenses
HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM.-$106,620
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
MARIA BEDNAREK PHDFellow & Hea-$0--
RICHARD DIMARCHI PHDProfessor &-$0--
SOUMITRA GHOSH PHDPresident-$0--
ANDREW PARKERSVP & Chief-$0--
ALEKSANDER SWIETLOWGlobal Direc-$0--
PANKAJ R PATELChairman & D-$0--
CLAUDIO SCHTEINGART PHDVP Science &-$0--
ADRIENNE DAY PHDBd.Sec. & Tr-$0--
GIRISH AAKALUVP Of Scient-$0--
YVONNE ANGELLDirector Of-$0--
RAJV SHARMARepresentati-$0--
Filing and Contact Details

Filer

Filer Name
Peptide Therapeutics Foundation
EIN
26-3728931
Phone
8586571511
Address
4245 SORRENTO VALLEY BLVD, SAN DIEGO, CA 92121

Signing Officer

Name
Adrienne Day Phd
Title
Bd.sec. & Treasurer
Phone
8586571511
Signed
2019-03-12

Preparer

Firm
GOODSELL & COMPANY INC CPA'S
Address
2665 4TH AVE, SAN DIEGO, CA 92103-6514
Preparer
Steven J Holc CPA
Phone
6192384343
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 8

Other income 2,618 total 2,618

Form 990-ez, Part I, Line 16

Expenses symposium expenses 101,325 foundation maintenance 2,297 board expenses 1,718 bank charges 30 total 105,370

Form 990-ez, Part II, Line 26

Accrued symposium expense 67,800 1,296

Form 990-ez, Part III

The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.

Form 990-ez, Part III, Line 28

Hold a peptide therapeutics symposium to bring together world leaders from academia, the biopharmaceutical industry, cmos, cros, and investors interested in all aspects of peptide r&d, including drug discovery, safety and toxicology, clinical develoment, manufacturing, pharmaceutical development, formulation, drug delivery and regulatory affairs. The organization also provided 13 postdoctoral fellows and graduate students with free registration to the symposium.

Raw XML Appendix184 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990EZ/BooksInCareOfDetail/PhoneNum08586571511
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt04245 SORRENTO VALLEY BLVD
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0SAN DIEGO
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd092121
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0478564
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0433418
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt089970
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt021358
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt01250
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0478564
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0433418
IRS990EZ/GrossReceiptsAmt0127978
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0410764
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0432122
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0410764
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0432122
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt0000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt1000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt2000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt3000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt4000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt5000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt6000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt7000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt8000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt9000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt10000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt90
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt100
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0MARIA BEDNAREK PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1RICHARD DIMARCHI PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2SOUMITRA GHOSH PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3ANDREW PARKER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4ALEKSANDER SWIETLOW
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5PANKAJ R PATEL
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6CLAUDIO SCHTEINGART PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7ADRIENNE DAY PHD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm8GIRISH AAKALU
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm9YVONNE ANGELL
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm10RAJV SHARMA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0FELLOW & HEA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1PROFESSOR &
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3SVP & CHIEF
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4GLOBAL DIREC
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5CHAIRMAN & D
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6VP SCIENCE &
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7BD.SEC. & TR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt8VP OF SCIENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt9DIRECTOR OF
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt10REPRESENTATI
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt0105370
IRS990EZ/OtherRevenueTotalAmt02618
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY.
IRS990EZ/ProgramServiceRevenueAmt035390
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt0106620
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0CA
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt067800
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt01296
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0106620
IRS990EZ/TotalProgramServiceExpensesAmt0106620
IRS990EZ/TotalRevenueAmt0127978
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.PEPTIDETHERAPEUTICS.ORG
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0OTHER INCOME 3,492
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0PART III, LINE 12
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt089970
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt0134940
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt089940
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt0104970
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt0104940
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0524760
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt035390
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt037634
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt046260
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt037788
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt032735
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0189807
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearAmt02618
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus1YearAmt0874
IRS990ScheduleA/OtherIncome509Grp/TotalAmt03492
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99510
IRS990ScheduleA/PublicSupportPY509Pct00.99590
IRS990ScheduleA/PublicSupportTotal509Amt0714567
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0125360
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0172574
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0136200
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0142758
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0137675
IRS990ScheduleA/Total509Grp/TotalAmt0714567
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0127978
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0173448
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0136200
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0142758
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0137675
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0718059
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0OTHER INCOME 2,618 TOTAL 2,618
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1EXPENSES SYMPOSIUM EXPENSES 101,325 FOUNDATION MAINTENANCE 2,297 BOARD EXPENSES 1,718 BANK CHARGES 30 TOTAL 105,370
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2ACCRUED SYMPOSIUM EXPENSE 67,800 1,296
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 8
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART II, LINE 26
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990-EZ, PART III, LINE 28
ReturnHeader/BuildTS02019-02-21 02:37:17Z
ReturnHeader/BusinessOfficerGrp/PersonNm0ADRIENNE DAY PHD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0BD.SEC. & TREASURER
ReturnHeader/BusinessOfficerGrp/PhoneNum08586571511
ReturnHeader/BusinessOfficerGrp/SignatureDt02019-03-12
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0PEPTIDE THERAPEUTICS FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0PEPT
ReturnHeader/Filer/EIN0263728931
ReturnHeader/Filer/PhoneNum08586571511
ReturnHeader/Filer/USAddress/AddressLine1Txt04245 SORRENTO VALLEY BLVD
ReturnHeader/Filer/USAddress/CityNm0SAN DIEGO
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd092121
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId05D07FE3862598DFA09B2BC5D6C67A36B8BA055E7
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId05D07FE3862598DFA09B2BC5D6C67A36B8BA055E7
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt098.171.214.221
ReturnHeader/FilingSecurityInformation/IPDt02019-03-28
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0CD
ReturnHeader/FilingSecurityInformation/IPTm000:29:46
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0331005644
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0GOODSELL & COMPANY INC CPA'S
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt02665 4TH AVE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0SAN DIEGO
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0921036514
ReturnHeader/PreparerPersonGrp/PhoneNum06192384343
ReturnHeader/PreparerPersonGrp/PreparationDt02019-03-27
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0STEVEN J HOLC CPA
ReturnHeader/ReturnTs02019-03-28T00:29:46-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02018-01-01
ReturnHeader/TaxPeriodEndDt02018-12-31
ReturnHeader/TaxYr02018

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings